---
figid: PMC4313578__nihms650999f3
figtitle: 'Therapeutic Targeting of Autophagy: Potential and Concerns in Treating
  Cardiovascular Disease'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4313578
filename: nihms650999f3.jpg
figlink: /pmc/articles/PMC4313578/figure/F3/
number: F3
caption: Hormones (insulin) and growth factors (IGF-1) signal through the PI3K/AKT
  pathway. AKT phosphorylates TSC2 and inhibits the TSC1/2 complex, leading to conversion
  of inactive RHEB-GDP to active RHEB-GTP and subsequent activation of mTORC1. Abundance
  of amino acids activate mTORC1 through RAG GTPases. AKT also activates mTORC1 by
  phosphorylating PRAS40, which is a negative regulator of mTORC1. AMPK is activated
  in response to low ATP levels and inactivates mTORC1 by phosphorylating TSC2 and
  RAPTOR. Resveratrol, metformin, and statins activate AMPK. Rapamycin inhibits mTOR
  activity.
papertitle: 'Therapeutic Targeting of Autophagy: Potential and Concerns in Treating
  Cardiovascular Disease.'
reftext: Amabel M. Orogo, et al. Circ Res. ;116(3):489-503.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9606748
figid_alias: PMC4313578__F3
figtype: Figure
redirect_from: /figures/PMC4313578__F3
ndex: 0b898c28-ded7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4313578__nihms650999f3.html
  '@type': Dataset
  description: Hormones (insulin) and growth factors (IGF-1) signal through the PI3K/AKT
    pathway. AKT phosphorylates TSC2 and inhibits the TSC1/2 complex, leading to conversion
    of inactive RHEB-GDP to active RHEB-GTP and subsequent activation of mTORC1. Abundance
    of amino acids activate mTORC1 through RAG GTPases. AKT also activates mTORC1
    by phosphorylating PRAS40, which is a negative regulator of mTORC1. AMPK is activated
    in response to low ATP levels and inactivates mTORC1 by phosphorylating TSC2 and
    RAPTOR. Resveratrol, metformin, and statins activate AMPK. Rapamycin inhibits
    mTOR activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - APRT
  - MFAP1
  - ATP8A2
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RHEB
  - RHEBP1
  - MTG1
  - MTOR
  - RPTOR
  - FOXO1
  - FOXO3
  - RBFOX3
  - F3
  - AKT1S1
  - RRAGA
  - DEPTOR
  - RRAGC
  - MLST8
  - Metformin
  - Rapamycin
  - Cancer
---
